Inspiration Healthcare’s neonatal strategy clearly working says Cenkos


Inspiration Healthcare PLC’s results today underline the progress it has made with both acquisitions and its neonatal strategy, said Cenkos.

Interim revenues rose by 47%, supported by the contribution of SLE, acquired in July 2020, while gross margin improved to 52.5% from 51.4% and underlying profits jumped by 42%.

“We believe these results clearly demonstrate the group-level benefits from both recent acquisitions (SLE and Viomedex) generating revenue synergies and margin improvements,” said Cenkos.

The broker has upgraded its 2022 estimates by 12% to GBP3.5mln from GBP3.2mln, reflecting improved gross margin and lower cash-based costs.

Buy says the broker, with the shares today up by 8% to 126.5p.


Please enter your comment!
Please enter your name here